ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer

• Main Authors: Aysegul Gorur (Author), Recep Bayraktar (Author), Cristina Ivan (Author), Hamada Ahmed Mokhlis (Author), Emine Bayraktar (Author), Nermin Kahraman (Author), Didem Karakas (Author), Selda Karamil (Author), Nashwa N. Kabil (Author), Pinar Kanlikilicer (Author), Burcu Aslan (Author), Lulufer Tamer (Author), Zhihui Wang (Author), Vittorio Cristini (Author), Gabriel Lopez-Berestein (Author), George Calin (Author), Bulent Ozpolat (Author)
• Format: Book
• Published: Elsevier, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Deregulation of noncoding RNAs, including microRNAs (miRs), is implicated in the pathogenesis of many human cancers, including breast cancer. Through extensive analysis of The Cancer Genome Atlas, we found that expression of miR-22-3p is markedly lower in triple-negative breast cancer (TNBC) than in...